Background & Aims-Immunodeficiency and autoimmune sequelae, including colitis, develop in patients and mice deficient in Wiskott-Aldrich Syndrome protein (WASP), a hematopoieticspecific intracellular signaling molecule that regulates the actin cytoskeleton. Development of colitis in WASP-deficient mice requires lymphocytes; transfer of T cells is sufficient to induce colitis in immunodeficient mice. We investigated the interactions between innate and adaptive immune cells in mucosal regulation during development of T-cell-mediated colitis in mice with WASP-deficient cells of the innate immune system.
Introduction
Over the past two decades, numerous murine models of inflammatory bowel disease (IBD) demonstrate a critical role for effector T cell populations in inducing intestinal inflammation 1, 2 . More recently, primary defects in the innate immune system have been shown to be sufficient to trigger colitis, either in the presence or absence of an adaptive immune system [3] [4] [5] [6] [7] [8] [9] [10] . Moreover, primary immune deficiencies, which can affect both the innate and adaptive immune compartments, are frequently associated with intestinal inflammation 11 . However, because of the broad distribution of immune cells affected by immunodeficiencies, the precise roles of the adaptive and innate immune compartments during initiation of an inflammatory response remain unclear.
Patients with Wiskott-Aldrich Syndrome (WAS) are devoid of or have functional defects in the Wiskott-Aldrich Syndrome protein (WASP). These individuals are immunodeficient with up to 5-10% of patients developing IBD [12] [13] [14] . Similarly, WASP-deficient (WKO) animals on the 129 SvEv background also develop spontaneous colitis 15, 16 . Interestingly, polymorphisms in Arpc2, a member of the WASP-interacting Arp2/3 complex in humans that is directly activated by WASP, has been associated with increased risk of human ulcerative colitis 31 .
WASP expression is restricted to hematopoietic lineages and regulates the actin cytoskeleton controlling leukocyte migration and a variety of effector functions 17 . However, for both WASP-deficient patients and mice, the specific role of WASP in adaptive and innate immune cells in disease initiation is not defined.
Colitis development in WKO mice is lymphocyte dependent as WASP/Recombination activating gene-2 (RAG) double knockout mice are devoid of colonic inflammation 16 . Moreover, WKO CD4 + T cells are sufficient to induce disease when transferred into immunodeficient RAG KO mice 16 . Since naturally-occurring Tregs are defective in WKO mice [26] [27] [28] [29] [30] , colitis may be mediated in part by dysfunctional Tregs. However, since innate immune cells from WKO mice have multiple cellular abnormalities and innate immune defects in other models have been shown to influence Treg homeostasis 5 , we hypothesized that WASP deficiency in innate immune cells plays a critical role in colitis development. In this regard, WASP deficiency in myeloid cells lead to defects in processes dependent on rearrangement of the actin cytoskeleton (e.g., chemotaxis, immune synapse formation, antigen presentation) [18] [19] [20] [21] [22] [23] [24] [25] . To test the hypothesis that WKO innate immune cell abnormalities play a critical role in disease development, we generated chimeric mice containing wild-type (WT) CD4 + T cells and WASP-deficient innate immune cells. These chimeric mice rapidly developed severe colitis, suggesting that WASP is required in innate immune cells to prevent intestinal inflammation. Herein, we explore the role of WASP in the crosstalk between aberrant innate immune cells and normal adaptive immune cells in the pathogenesis of colitis.
Results

WASP-deficient innate immune cells induce colitogenicity in WT CD4 + T cells
We previously reported that, in contrast to WKO mice, WASP -/-RAG-2 -/-double knockout (WRDKO) mice on a 129 SvEv background do not develop spontaneous colitis 16 . We hypothesized that the colitis in WKO mice, although lymphocyte-dependent, might be initiated by defects in the innate immune compartment. To investigate whether WASPdeficient innate immune cells could induce WT CD4 + T cells to be colitogenic, we transferred unfractionated WT or WKO CD4 + T cells into WRDKO mice ( Figure 1A ). These chimeric mice (referred throughout the text as WT-DKO chimeric mice for WT T cells in WRDKO mice) have WT CD4 + T cells but WASP-deficient innate immune cells. Recipient animals of WT CD4 + T cells rapidly lost weight ( Figure 1B ) and developed severe colitis ( Figure 1C and 1D) with early mortality comparable to recipients of WKO CD4 + T cells. This is contrast to our prior results demonstrating that transfer of WT unfractionated CD4 + cells into RAG KO mice, whose innate immune cells express WASP, does not induce colitis 16 . Therefore, severe colitis developed rapidly in the presence of WASP-deficient innate immune cells independent of WASP expression in CD4 + T cells.
Next, we determined whether T cells that were previously exposed to a WASP-deficient innate immune cell environment were permanently imprinted with colitogenic properties. CD4 + T cells from WT-DKO chimeric mice were used in a secondary transfer into RAG KO or WRDKO mice (Supplementary Figure 1A) . While WRDKO recipients developed severe disease upon secondary transfer of CD4 + T cells from WT-DKO chimeric mice, there was no clinically significant disease in RAG KO recipients (Supplementary Figure 1B and S1C), indicating WASP-deficient innate immune cells do not permanently imprint WT T cells to become colitogenic.
Given autoimmune disease can develop in CD4 + adoptive cell transfer experiments when limited numbers of donor WT CD4 + cells are used (a setting in which the regulatory T cell repertoire is limited 32 ), we examined whether varying the number of donor CD4 + cells affected disease outcome in WRDKO recipients. Irrespective of the number of donor CD4 + cells transferred (0.5 million to 3 million), the severity of colitis remained unchanged ( Figure 1E ) with disease present as early as one week after cell transfer (data not shown).
WT naïve T cells but not Tregs induce colitis in WRDKO recipients
As described above, the transfer of unfractionated CD4 + T cells induces rapid and severe colonic inflammation in WRDKO mice. In order to assess whether specific T cell subsets were responsible for the observed phenotype, we examined whether fractionating CD4 + cells into naïve (Tnaïve: CD4 + CD45RB hi CD25 -) and regulatory (Treg: CD4 + CD45RB lo CD25 + ) T cell subsets would alter disease severity following cell transfer (Figure 2A ). When WRDKO mice received only WT Tnaïves, recipient animals lost weight rapidly within 2 weeks associated with severe colitis and early mortality ( Figure 2B and 2C).
WRDKO recipients of WT Tregs demonstrated no disease ( Figure 2B and 2C) . Similar transfer of WT Tnaïves into RAG KO mice, which have WASP-expressing innate immune cells, did not induce clinically significant disease in the timeframe of our experiments ( Figure 2D-2F) , consistent with previously published data 33 , and emphasizing the profound colitogenicity seen in WRDKO hosts. These data demonstrate that WT Tnaïves, but not Tregs, become colitogenic after interacting with WASP-deficient innate immune cells.
T cell expansion, but not apoptosis, is altered in WRDKO hosts
To elucidate the mechanism by which WT-DKO chimeric mice develop severe and early onset colitis, we investigated CD4 + T cell expansion and survival in the setting of WASPdeficient innate immune cells. We observed a higher absolute number of CD4 + cells in the lamina propria (LP) of WRDKO compared to RAG KO recipients of WT Tnaïves (Supplementary Figure 2A) . To assess directly the role of WASP-deficient innate immune cells on T cell proliferation, RAG KO and WRDKO recipients of WT Tnaïves were injected with BrdU two weeks post T cell transfer and lymphoid organs were harvested 16 hours following BrdU administration. There was a significant increase in the BrdU + CD4 + population from LP in WRDKO mice compared to RAG KO mice (Supplementary Figure  2B and S2C). Lastly, we investigated whether a decrease in T cell apoptosis might account for the higher CD4 + T cell counts in the LP of WRDKO recipients of WT CD4 + T cells. The percent of apoptotic cells (Annexin V + 7AAD -) in the LP were similar in both WRDKO and RAG KO recipients (data not shown). In summary, the increased LP T cell numbers observed in WRDKO recipients correlated with an increase in early T cell proliferation after Tnaïve transfer without evidence of decreased apoptosis.
WT Tregs fail to suppress normally in vivo in the presence of WASP-deficient innate immune cells
We next expanded our T cell analysis to include regulatory T cell activity and sought to address whether WT Tregs were functionally suppressive in the setting of WASP-deficient innate immune cells. We transferred WT Tregs along with WT Tnaïves at a 1:1 ratio into WRDKO recipients (the Treg:Tnaïve ratio used in the standard CD45RB transfer model is 1:4) ( Figure 3A ). Nevertheless, despite the higher Treg:Tnaïve ratio, there was no protection from colitis ( Figure 3B-3D ). Partial protection was observed only when the Treg:Tnaïve ratio was 8 times the usual required ratio (i.e., 2:1, Figure 3B -3D). Of note, similar Treg:Tnaïve 1:1 transfer into RAG KO mice demonstrated full protection of colitis with a mean histologic colitis score of 0.45 out of 8 (n = 11). Overall, these data indicate that WT Tregs can suppress only when present at increased numbers in the setting of WASPdeficient innate immune cells.
WASP-deficient innate immune cells lead to defects in Treg homeostasis
We hypothesized that the aberrant Treg suppressive activity noted in vivo might result from impaired Treg expansion, survival, and/or adaptive Treg generation in WRDKO mice. We therefore assessed the proportion of Tregs in WRDKO and RAG KO mouse recipients of WT Tnaïves alone and noted that the proportion of generated Tregs was significantly lower in the MLN and the LP of WRDKO mice compared to RAG KO recipients ( Figure 4A and 4B). To assess in vitro whether WASP-deficient innate immune cells, specifically DCs, demonstrate defects in facilitating Treg induction, Tnaïves were cultured in the presence of MLN DCs from RAG KO or WRDKO mice after T cell transfer under conditions that promote de novo generation of Tregs. MLN DCs from WRDKO mice were defective in their ability to generate Tregs compared to DCs from RAG KO mice in the absence or presence of low doses of TGF-β with rescue only in the presence of high doses ( Figure 4C and 4D). Thus, Treg generation was impaired in the presence of WASP-deficient innate immune cells both in vitro as well as in vivo.
In addition to defects in Treg generation, aberrant Treg expansion, survival, or maintenance could also contribute to defective Treg function observed in WRDKO recipient mice of Treg:Tnaïve co-transfer. To assess globally the outcome of these processes, we examined the percent of Tregs in recipients of unfractionated WT CD4 + T cells and found decreased Treg proportions in WRDKO compared to RAG KO recipients ( Figure 5A and 5B). To assess for a specific defect in Treg maintenance, we transferred Tregs expressing GFP under the Foxp3 promoter into RAG KO or WRDKO mice and assessed for the percentage of CD4 + Foxp3 + cells in MLN and LP two weeks after transfer. In this context, Foxp3-expressing cells were reduced in the MLN and LP of WRDKO compared to RAG KO mice ( Figure 5C and 5D ). Since this defect in Treg maintenance in the LP may be due to a decrease in Treg proliferation or an increase in Treg apoptosis, we assessed these parameters employing BrdU and Annexin V/7AAD staining, respectively, within the Foxp3GFP + population. While there was no increase in apoptosis (data not shown), proliferation was significantly impaired in WRDKO compared to RAG KO recipients of Tregs correlating with the reduction in Treg maintenance ( Figure 5E and5F) . Taken together, these data indicate that Treg generation and proliferation are defective in the presence of WASPdeficient innate immune cells.
Reduction in CD11b + CD103 + DC subset in WRDKO Mice
WASP-deficient DCs have known defects in chemotaxis, podosome formation, immune synapse formation, and antigen presentation 18-20, 24, 25 . Since DCs can regulate T cell activation, we hypothesized that WASP-deficient DCs may be the critically altered innate immune cell population affecting T cell homeostasis. We analyzed mucosal and peripheral DC populations in RAG KO and WRDKO mice after T cell transfer. To delineate macrophages and DC subsets, we defined plasmacytoid DCs (pDCs) as MHCII mid PDCA-1 + , conventional DCs (cDCs) as CD11c + CD11b -/lo , and monocytes/macrophages (Mφ) as CD11c -/lo CD11b hi ( Figure 6A , gating strategy depicted in Supplementary Figure 3A) . Following these criteria, there were no significant differences in the percentages of Mφ, cDCs, or pDCs in SPL, MLN, and LP of WRDKO mice when compared with RAG KO mice ( Figure 6B-D) . Given that CD103 + DCs have tolerogenic properties 34 , we analyzed the proportion of cDCs that are CD103 + and found decreased proportions in WRDKO in both the MLN as well as LP (Supplementary Figure 3B) . Moreover, recent data demonstrate that Treg and gut homing induction capacity reside within the CD8α -(which are CD11b + ) subset of CD103 + DCs 35 . Further analysis showed a decrease in the proportion of CD11b + CD103 + cDCs in the LP and MLN of WRDKO mice ( Figure 6E ). Thus, colitis in WT-DKO chimeric mice may be associated with a decrease in tolerogenic DCs.
Decreased IL-10 production is associated with WASP deficiency
The anti-inflammatory cytokines TGF-β and IL-10 are important for the generation and/or function of regulatory T cells 4, 5, 36 . Therefore, we investigated the expression levels of these two down-regulatory cytokines in our colitis model. We first analyzed cytokine transcript levels in the MLN and LP of RAG KO and WRDKO recipients following transfer with WT Tnaïve cells. As expected, quantitative real-time PCR analysis showed elevated transcript levels of pro-inflammatory cytokines IL-23p19, TNF-α, and IL-6 in the colon of WRDKO mice but surprisingly not in the MLN. However, transcripts of IL-10 were markedly reduced in the MLN, but not in the colon, of WRDKO recipient mice ( Figure 7A and 7B). Although elevated IL-10 transcripts were detected in the colons of WRDKO mice, this finding may be attributed to the increased T cell numbers resulting from severe colitis.
We then evaluated the production of these cytokines by WASP-deficient MLN DCs. WASPdeficient DCs secreted similar amounts of active TGF-β under stimulatory conditions and were able to activate exogenous latent TGF-β to a similar degree as control DCs (data not shown). In contrast, WASP-deficient MLN DCs transcribed and secreted less IL-10 in vitro under stimulatory conditions compared to WASP-expressing DCs ( Figure 7C ). Interestingly there was no statistically significant alteration in TNF-α, IFN-γ, IL-6, or IL-12 at the transcript or protein level (data not shown). Hence, these data suggest that CD4 + T cells reside in an altered cytokine environment in the MLN with reduced IL-10, which may influence their developmental program or function in WRDKO mice.
Colitis in WT-DKO chimeric mice results from a loss-of-function defect that can be prevented with IL-10 administration
Since WASP-deficient DCs exhibited defects in IL-10 secretion and may be associated with colitis development in WT-DKO mice, we determined whether colitis could be prevented with WASP + innate immune cells by generating mixed bone marrow chimeras. Lethally irradiated WT recipients received WRDKO bone marrow cells with or without RAG KO bone marrow cells (which express WASP) followed five weeks later by the transfer of WT Tnaïve cells (Supplementary Figure 4) . Chimeric animals receiving both WRDKO and RAG KO bone marrow cells did not develop disease ( Figure 7D ) despite equal reconstitution of WASP-deficient and WASP-sufficient bone marrow (data not shown). In contrast, control mice that received only WRDKO bone marrow cells developed colitis ( Figure 7D ). Protection against colitis induction by WASP-expressing innate immune cells suggests that colitis in WT-DKO chimeric mice results from a loss-of-function defect.
The observed reduction in IL-10 levels produced by WRDKO MLN DCs in vitro and by MLNs in WT-DKO chimeric mice in vivo prompted us to determine whether colitis in WT-DKO mice could be rescued by exogenous administration of IL-10. WT Tnaïve cells were transferred into WRDKO mice receiving exogenous IL-10-Ig or control Ig. In contrast to animals that had received control Ig, IL-10-Ig-treated animals were protected from colitis induction with no weight loss or histologic evidence of inflammation ( Figure 7E and 7F) . Collectively, these data show that the colitis susceptibility in WT-DKO mice is attributed to a loss-of-function defect in innate immune cells and can be rescued by administration of exogenous IL-10. Experiments addressing whether IL-10-Ig is acting directly upon innate immune cells or T cells are ongoing.
Discussion
WASP deficiency in humans and mice is associated with both immunodeficiency and autoimmune sequelae 11 . Inflammatory diseases in the setting of a primary genetic immunodeficiency, while perhaps seeming paradoxical, are quite common 37 . Since WASP expression is essential for the function of most leukocyte subtypes, the specific contribution of the adaptive and innate immune system to the pathogenesis of the associated autoimmunity has been unclear. Although Treg dysfunction has been noted in WASPdeficient T cells [26] [27] [28] [29] and may contribute to autoimmunity, in this current work, we demonstrated that WASP deficiency, when limited to the innate immune compartment, is sufficient to promote severe colitis development in the presence of WT CD4 + T cells.
Myeloid cells have been increasingly recognized as critical regulators of gut homeostasis [6] [7] [8] [9] [10] . Moreover, specific subsets (e.g., DCs) can have differential roles in immune modulation. Thus, appropriate crosstalk between the innate and adaptive immune system is often an essential component for maintaining mucosal homeostasis. Here we demonstrate that severe colonic inflammation occurs with rapid onset in WRDKO but not RAG KO recipients of WT CD4 + T cells. Our data demonstrate that WASP-deficient innate immune cells alter both regulatory and effector T cell arms of the adaptive immune system. WASP-deficient innate immune cells enhanced WT effector T cell function since WT naïve T cells without co-transfer of Tregs caused more severe and earlier onset disease when transferred into WRDKO compared to RAG KO recipients. WASP-deficient innate immune cells also led to increased CD4 + T cell proliferation after T cell transfer. This enhanced early T cell proliferation correlates temporally with the spontaneous phase of lymphopeniainduced proliferation that can be associated with effector T cell generation and autoreactivity 38 .
Nevertheless, it is possible that the observed enhanced T cell effector function (colitogenicty) and proliferation is secondary to altered Treg homeostasis in WRDKO hosts. The suppressive function of WT Tregs was markedly reduced in vivo in WRDKO hosts, despite co-transfer of sufficient number of WT Tregs. Likewise, Treg generation and proliferation were also depressed. Interestingly, Snuffner et al. demonstrated that homeostatic proliferation of Tregs in a lymphopenic host is hampered by deletion of DCs 39 consistent with the altered Treg homeostasis and reduction in CD103 + DCs, a population of DCs critical for de novo Treg generation 34 , in WRDKO hosts. In particular, the CD8α -subset of CD103 + DCs, which express CD11b and found to be reduced in WRDKO mice, also appears to be the specific DC subset with Treg-inducing potential 35 . While we and others demonstrated that expression of WASP is required for differentiation/maturation of specific leukocyte subsets and leukocyte migration 20, 21, 23, 24, 30, 40 , it remains unknown whether WASP is uniquely required for the differentiation/migration of CD103 + DCs in mucosal compartments.
The reduction in Treg generation, proliferation, and maintenance in the setting of WASPdeficient innate immune cells correlates with decreased IL-10 production by WASPdeficient DCs. Innate immune cell-derived IL-10 may be important for Treg generation 4 and function of Foxp3-expressing Tregs 5 . In addition, pathogenicity of WT CD4 + T cells is enhanced in mice devoid of IL-10 in innate immune cell compartments 4 implicating a shared pathogenic mechanism between IL-10/RAG DKO and WRDKO recipients of WT T cells. Thus, we speculate that defective Treg homeostasis in WRDKO hosts and the associated intestinal inflammation are due, at least in part, to impairment in IL-10 production. In our studies, reduced IL-10 transcription in the MLN of WT-DKO hosts may be related to the decrease in CD103 + DCs in the MLN since these cells are known to secrete IL-10 41 . In support of this, our data show that MLN DCs isolated from WRDKO mice produce less IL-10. The mechanistic underpinnings for defective IL-10 secretion in WASP-deficient DCs remains elusive, but regardless of the specific mechanism, a role for deficient IL-10 production in colitis development in WRDKO hosts is consistent with our bone marrow chimeric studies revealing a loss-of-function defect of WASP-deficient innate immune cells and the observed prevention of disease with exogenous IL-10-Ig treatment.
In summary, our data indicate that WASP-deficient aberrant innate immune cells can render WT T cells severely colitogenic. We speculate that WASP deficiency is associated with reductions in the generation, migration, and/or function of tolerogenic CD103 + DCs that lead to decreased IL-10 production in the MLN. This reduction in IL-10 results in both enhanced effector T cell activity as well as defects in Treg generation, expansion, and suppressive function. Taken together, intestinal inflammation in mice and humans resulting from WASP deficiency may arise, at least in part, from primary innate immune abnormalities resulting in aberrant innate-adaptive immune cell crosstalk. (A) Cytokine mRNA levels by qRT-PCR on whole colons of RAG KO and WRDKO recipients of WT Tnaïves, n = 7 for RAG KO; n = 9 for WRDKO with * p for TGF-β1 = 0.02, * p for IL-23p19 = 0.04, * p for IL-6 = 0.02, ** p for TNF-α = 9 × 10 -3 . (B) Cytokine mRNA levels on whole MLNs with n = 4 for RAG KO; n = 6 for WRDKO with * p for IL-10 = 0.02, * p for IL-6 =0.02, * p for TNF-α = 0.02. (C) Mean IL-10 mRNA levels ± SEM detected by qRT-PCR (left) and mean IL-10 protein levels ± SEM (right) of RAG KO and WRDKO MLN DCs stimulated in vitro with or without LPS (U/S), n = 5-6 pooled from
